APOB and cancer: In approximately 75% of cancer types and about 50% of all cancers analyzed, mutations associated with the apolipoprotein B mRNA-editing enzyme catalytic polypeptide (APOBEC; A) represent one of the most common endogenous mutational mechanisms in cancer [72].